Think Research Corporation (TSX-V:THNK, OTCQB:THKKF) said it has been contracted by a major US-based pharmacy to deliver business intelligence and support solutions to more than 1,700 pharmacies servicing 5.5 million patients throughout the United States.
The Toronto-based clinical content and technology company said the contract is a direct result of the acquisition and subsequent integration of Pharmapod Ltd in the second half of fiscal 2021.
"We are pleased that this US pharmacy retailer has entrusted Think to provide the essential data, intelligence, and workflow solutions required for modern pharmacies and their pharmacists to improve quality, safety, and compliance,” Think CEO Sachin Aggarwal said in a statement.
READ: Think Research says its subsidiary BioPharma Services achieves another successful FDA inspection result
“Our highly configurable cloud-based solutions are being deployed now with minimal disruption to operations, which will soon give up to 5,000 pharmacists access to these powerful solutions that will help 6.8 million patients gain improved health outcomes," he added.
Through its recent acquisition of Pharmapod, Think delivers essential data, business intelligence and related workflow solutions to approximately 11,000 pharmacies throughout Canada, the United States, the United Kingdom, Ireland and Australia, including 65% of all Canadian retail pharmacies.
Aggarwal said Think’s ability to reliably capture, structure and standardize data in real-time sets the company apart from its competitors.
Think Research is an industry leader in delivering knowledge-based digital healthcare software solutions. The company's focused mission is to organize the world's health knowledge so everyone gets the best care. Its evidence-based healthcare technology solutions support the clinical decision-making process, standardize care, and improve patient outcomes.
Contact the author at jon.hopkins@proactiveinvestors.com